Thus, all patients with low hypodiploid ALL should be tested for a germline TP53 pathogenic variant (e.g., Li-Fraumeni syndrome, a well-known hereditary cancer predisposition syndrome [39]). The gene discussed is TP53; the disease is acute lymphoblastic leukemia.